| Schedule of Stock-Based Compensation Expense |
Stock-based compensation included in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) is as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | Six Months Ended June 30, | | 2026 | | 2025 | 2026 | | 2025 | | Cost of revenue | $ | 2,665 | | | $ | 1,955 | | $ | 4,763 | | | $ | 3,712 | | | Selling and marketing | 13,822 | | | 14,329 | | 24,342 | | | 26,426 | | | Research and development | 19,892 | | | 18,643 | | 36,877 | | | 34,831 | | | General and administrative | 14,968 | | | 10,477 | | 27,168 | | | 18,762 | | | Stock-based compensation, net of amounts capitalized | 51,347 | | | 45,404 | | 93,150 | | | 83,731 | | | Capitalized stock-based compensation expense | 1,093 | | | 1,480 | | 1,947 | | | 2,587 | | | Total stock-based compensation expense | $ | 52,440 | | | $ | 46,884 | | $ | 95,097 | | | $ | 86,318 | |
|